Dr. Wael Adel Samuel Hanna, MD

Dr. Hanna practices at Vascular Center Dallas in Dallas, Texas.

Dr. Hanna's NPI, 1932339868, was assigned on July 27, 2009. Dr. Hanna graduated from Cairo University School of Medicine in 2003. Dr. Hanna's Texas license number on file is S7227.

Dr. Hanna's primary practice is Vascular Center Dallas, at 3604 Live Oak Street Suite 300, Dallas, TX 75204. The practice phone is (214) 358-2300.

Dr. Hanna's primary practice is Vascular Center Dallas in Dallas, Texas. Dr. Hanna is also affiliated with Methodist Dallas Medical Center. The medical group on file is Dallas Nephrology Associates. Dmand AI also links Dr. Hanna to 1 more hospital, 4 medical groups, 3 group practices and clinics and 2 dialysis centers, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hanna practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Hanna's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Hanna is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Hanna's licenses on file in 3 states: Texas, Arizona and Pennsylvania.

Dmand AI lists chronic kidney disease among the conditions Dr. Hanna treats.

CMS data shows 1,865 Medicare services from Dr. Hanna across 10 procedure codes in 2024, for 410 Medicare patients. Medicare paid $150,473 for them.

CMS counts 410 Medicare patients who saw Dr. Hanna in 2024. The largest group is under 65, with 209 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 29% are also on Medicaid. Their average risk score is 5.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hanna's median patient age at 62, with 48% women.

In 2024, Dr. Hanna wrote 2,384 Medicare Part D claims for 388 patients. 85% of them were for generic drugs. CMS names the drug for 1,985 of them, across 46 drugs with 11 or more claims each, at $150,043 in total drug cost. In 2023, CMS named 1,869 claims across 38 drugs.

Dr. Hanna accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hanna as offering telehealth.

Dmand AI links 6 papers to Dr. Hanna, published from 2019 to 2023. 2019 was the busiest year, with 4. The most frequent topics are Kidney, Acute Kidney Injury and Tissue Donors. Dr. Hanna's most frequent co-authors are James Paul Reichart, MD, Raymond L. Heilman, MD and Caroline Jadlowiec, MD.

Dmand AI links Dr. Hanna to 2 clinical trials, 2 of them phase 2 studies. Conditions studied include Lung Neoplasms and Thoracic Neoplasms. McMaster University sponsors the most, 2.

CMS Open Payments shows 276 general payments to Dr. Hanna from 49 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,502.

Dr. Hanna graduated from Cairo University School of Medicine in 2003. Dr. Hanna is a member of ACP and SHM.

Dr. Hanna is in network with 24 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.